ViroSphere 2027: Emerging Viral Threats, Infectious Diseases, Antimicrobial Resistance & Public Health Emergencies
Theme: "Emerging Viral Threats, Infectious Diseases, Antimicrobial Resistance & Public Health Emergencies"
📅Date: 22–23 April 2027 | 📍Venue: Crowne Plaza Orlando Lake Buena Vista, Orlando, Florida, USA
About the Conference
ViroSphere 2027 is a premier international conference dedicated to advancing scientific knowledge, innovation, and global collaboration in the fields of virology, infectious diseases, antimicrobial resistance (AMR), epidemiology, and public health preparedness. Taking place on 22–23 April 2027 in Orlando, Florida, USA, the conference will bring together renowned researchers, clinicians, healthcare professionals, epidemiologists, microbiologists, pharmaceutical scientists, policymakers, and industry leaders from around the world.
As emerging viral diseases continue to pose significant global health challenges, ViroSphere 2027 provides an interdisciplinary platform to discuss the latest scientific discoveries, diagnostic technologies, vaccine development, antiviral therapies, AMR mitigation strategies, and emergency response frameworks. The conference aims to foster international partnerships and inspire innovative solutions that strengthen global health security.
Participants will benefit from keynote lectures, scientific presentations, panel discussions, workshops, poster sessions, networking opportunities, and industry exhibitions showcasing cutting-edge technologies and healthcare innovations.
Why Attend ViroSphere 2027?
• Learn from internationally recognized experts in virology and infectious diseases.
• Explore the latest breakthroughs in viral diagnostics, vaccines, therapeutics, and precision medicine.
• Discover innovative approaches to combating antimicrobial resistance.
• Gain insights into pandemic preparedness and global public health policies.
• Present your latest research to an international scientific audience.
• Network with leading researchers, clinicians, healthcare professionals, and industry innovators.
• Participate in engaging panel discussions, workshops, and poster presentations.
• Connect with pharmaceutical companies, biotechnology organizations, public health agencies, and academic institutions.
Who Should Attend?
• Virologists
• Infectious Disease Specialists
• Clinical Microbiologists
• Epidemiologists
• Immunologists
• Public Health Professionals
• Physicians and Clinicians
• Medical Researchers
• Pharmacologists
• Vaccine Researchers
• Antimicrobial Resistance Experts
• Molecular Biologists
• Biotechnology Professionals
• Pharmaceutical Scientists
• Healthcare Administrators
• Government and Public Health Officials
• Laboratory Scientists
• Academic Researchers
• Graduate Students and Postdoctoral Fellows
• Industry Representatives
Key Highlights
• International Keynote Speakers
• Invited Expert Talks
• Oral and Poster Presentations
• Young Researcher Forum
• Best Presentation Awards
• Industry Exhibitions
• Networking Sessions
• Collaborative Research Opportunities
• Publication Opportunities
• Certificate of Participation
• Hybrid Participation (In-Person & Virtual)
Important Dates
• Abstract Submission Deadline:
• Early Bird Registration:
• Conference Dates:
Abstract Submission Guidelines
Abstracts must be submitted online through the conference portal.
Word Limit: 250–300 words
Format: Include title, authors, affiliation, email address, and 3–5 keywords
Notification of Acceptance: Within 10 working days after submission
Call for Papers
Researchers, academicians, industry experts, practitioners, policymakers, and students are invited to submit original research abstracts and papers addressing current challenges and innovative solutions in climate change, environmental sustainability, artificial intelligence, and clean energy. Accepted submissions will be presented during the conference and considered for publication opportunities in associated journals.
All registered participants of Scientific Research Conferences 2026 will receive a Certificate of Attendance accredited with 10 CPD Credits
Registration Fee & Cancellation Policy: Upon confirmation of your participation, the registration fee is due to secure your slot. Please note that all payments are final and non-refundable. However, should you be unable to attend in person, you may transfer your registration to a colleague at no additional cost, or convert your participation to a virtual format to present remotely. Alternatively, your fee can be applied toward the publication of your article in the conference proceedings and associated journals, or held as a credit to be used for any of our future upcoming events.
About Florida, USA
Florida, known as the "Sunshine State," is one of the United States' most dynamic and internationally connected destinations. Renowned for its warm climate, beautiful coastlines, world-class attractions, and thriving life sciences and healthcare sectors, Florida offers an inspiring setting for global conferences and scientific collaboration.
As a hub for medical research, biotechnology, public health, and innovation, Florida is home to leading universities, research institutions, healthcare organizations, and biomedical companies. Its excellent infrastructure, international accessibility, and multicultural environment make it an ideal destination for researchers, healthcare professionals, and industry leaders from around the world.
Visitors can also enjoy Florida's vibrant culture, diverse cuisine, beautiful beaches, and iconic attractions, making their conference experience both professionally rewarding and personally memorable.
Join ViroSphere 2027
Be part of a global scientific gathering dedicated to addressing today's most pressing infectious disease challenges. Join distinguished experts, healthcare leaders, researchers, and innovators in Orlando, Florida, to exchange knowledge, inspire collaboration, and shape the future of infectious disease research, antimicrobial stewardship, and public health preparedness. Together, we can build resilient healthcare systems and advance solutions for a healthier, safer world.
Contact at
Preliminary Program
ViroSphere 2027: Emerging Viral Threats, Infectious Diseases, Antimicrobial Resistance & Public Health Emergencies
Theme: "Emerging Viral Threats, Infectious Diseases, Antimicrobial Resistance & Public Health Emergencies"
📅 Date: 22–23 April 2027
📍 Venue: Crowne Plaza Orlando Lake Buena Vista, Orlando, Florida, USA
Day 1 – April 22, 2027
09:30 – 10:30 | Keynote Session
Emerging Viral Diseases and Global Health
Global perspectives on emerging viral threats, outbreak preparedness, international surveillance systems, pandemic resilience, and collaborative public health strategies.
10:30 – 11:00 | Coffee Break & Networking
11:00 – 12:00 | Session
Novel and Re-Emerging Infectious Diseases
Current advances in emerging pathogens, zoonotic disease transmission, outbreak investigations, pathogen evolution, and innovative prevention strategies.
12:00 – 13:00 | Session
Clinical Virology and Viral Pathogenesis
Mechanisms of viral infection, host-pathogen interactions, viral replication, disease progression, immune responses, and translational clinical research.
13:00 – 14:00 | Lunch Break
14:00 – 15:00 | Session
Viral Evolution, Genomics and Molecular Epidemiology
Genomic surveillance, viral mutation analysis, molecular diagnostics, pathogen sequencing, evolutionary biology, and outbreak tracking technologies.
15:00 – 16:00 | Session
Emerging Respiratory Viruses
Research on respiratory viral infections, transmission dynamics, diagnostics, therapeutics, vaccine development, and healthcare preparedness.
16:00 – 16:30 | Coffee Break
16:30 – 17:30 | Session
Influenza Research and Prevention
Seasonal and pandemic influenza surveillance, vaccine innovations, antiviral therapies, epidemiology, and global influenza control programs.
17:30 – 18:30 | Poster Session & Networking
Researchers present innovative findings in virology, infectious diseases, antimicrobial resistance, molecular diagnostics, vaccines, epidemiology, and public health preparedness.
Day 2 – April 23, 2027
09:00 – 10:00 | Keynote Session
Coronavirus Research and Pandemic Preparedness
Advances in coronavirus biology, next-generation vaccines, antiviral therapeutics, public health preparedness, surveillance systems, and future pandemic response strategies.
10:00 – 11:00 | Session
Arboviral Diseases (Dengue, Zika, Chikungunya & Yellow Fever)
Vector-borne disease surveillance, mosquito control strategies, vaccine research, diagnostics, climate impacts, and global disease prevention.
11:00 – 11:30 | Coffee Break & Networking
11:30 – 12:30 | Session
Ebola, Marburg and Viral Hemorrhagic Fevers
Advances in diagnostics, therapeutics, outbreak containment, biosafety, vaccine development, and emergency response for high-consequence viral diseases.
12:30 – 13:30 | Session
HIV/AIDS Research and Therapeutics
Novel HIV therapeutics, vaccine research, antiretroviral treatment strategies, immune modulation, prevention technologies, and long-term disease management.
13:30 – 14:30 | Lunch Break
14:30 – 15:30 | Session
Antimicrobial Resistance and Global Infection Control
Emerging antimicrobial resistance, antimicrobial stewardship, hospital-acquired infections, rapid diagnostics, infection prevention, and novel therapeutic approaches.
15:30 – 16:30 | Session
Artificial Intelligence, Molecular Diagnostics and Genomic Surveillance in Infectious Diseases
AI-assisted diagnostics, genomic sequencing, predictive outbreak analytics, digital epidemiology, precision public health, and next-generation laboratory technologies.
16:30 – 17:00 | Coffee Break
17:00 – 18:00 | Session
One Health, Zoonotic Diseases and Future Pandemic Preparedness
Integrated human, animal, and environmental health approaches, zoonotic disease surveillance, biosafety, biosecurity, pandemic resilience, and global collaborative response systems.
18:00 – 18:30 | Panel Discussion
Future Directions in Virology, Infectious Diseases and Global Public Health
International experts discuss emerging viral threats, antimicrobial resistance, vaccine innovation, pandemic preparedness, global health policy, and future research priorities.
18:30 – 19:00 | Closing Remarks & Awards
Conference summary, certificate distribution, best oral and poster presentation awards, appreciation to speakers and delegates, and closing ceremony.
Conference sessions
Browse the current session list for ViroSphere 2027: Emerging Viral Threats, Infectious Diseases Antimicrobial Resistance & Public Health Emergencies.
Bioinformatics and Computational Virology
This session explores the application of bioinformatics and computational approaches in virology, including viral genome analysis, phylogenetics, molecular evolution, structural modeling, AI-driven data analysis, and computational tools for virus surveillance, diagnostics, vaccine development, and antiviral drug discovery.
Digital Health and Disease Monitoring
This session explores the use of digital health technologies for infectious disease monitoring, including wearable devices, mobile health applications, telemedicine, electronic health records, and real-time surveillance systems. It highlights innovations that improve early detection, disease tracking, public health decision-making, and patient care.
Environmental Health and Emerging Pathogens
This session focuses on the impact of environmental factors on the emergence and spread of infectious pathogens. It covers environmental surveillance, climate change, zoonotic diseases, antimicrobial resistance, water and air quality, and innovative strategies to detect, prevent, and control emerging infectious threats for improved public health.
Artificial Intelligence in Infectious Disease Surveillance
This session explores the application of artificial intelligence in infectious disease surveillance, focusing on early outbreak detection, predictive modeling, real-time data analytics, digital epidemiology, and decision-support systems to enhance disease monitoring, public health preparedness, and rapid response.
Hospital-Acquired Infections & Infection Prevention
This session focuses on the prevention, surveillance, diagnosis, and management of hospital-acquired infections (HAIs). It highlights infection prevention and control practices, antimicrobial stewardship, healthcare-associated pathogen surveillance, emerging technologies, and strategies to improve patient safety and reduce healthcare-associated infections.
Foodborne and Waterborne Infectious Diseases
This session focuses on infectious diseases transmitted through contaminated food and water, emphasizing their prevention, detection, diagnosis, treatment, and control. It covers outbreak surveillance, food and water safety, antimicrobial resistance, emerging pathogens, and public health strategies to reduce the global burden of these infections.
HIV/AIDS Research and Therapeutics
This session explores the latest advances in HIV/AIDS research, including viral pathogenesis, diagnostics, antiretroviral therapies, drug resistance, vaccine development, and cure strategies. It highlights innovations in prevention, clinical management, personalized treatment, and global initiatives aimed at improving patient outcomes and ending the HIV/AIDS epidemic.
Ebola, Marburg and Viral Hemorrhagic Fevers
This session focuses on Ebola, Marburg, and other viral hemorrhagic fevers, addressing their epidemiology, transmission, pathogenesis, clinical management, diagnostics, and outbreak response. It highlights advances in vaccines, therapeutics, infection prevention, surveillance, and global preparedness to mitigate the impact of these high-consequence viral diseases.
Arboviral Diseases (Dengue, Zika, Chikungunya & Yellow Fever)
This session explores the epidemiology, transmission, clinical manifestations, diagnosis, prevention, and control of major arboviral diseases, including dengue, Zika, chikungunya, and yellow fever. It highlights advances in vector surveillance, vaccine development, antiviral research, outbreak response, and integrated strategies to reduce the global burden of mosquito-borne viral infections.
Coronavirus Research and Pandemic Preparedness
This session focuses on the latest advancements in coronavirus research, including viral biology, transmission, diagnostics, therapeutics, and vaccine development. It highlights lessons learned from recent pandemics, innovative surveillance approaches, preparedness planning, and global strategies to strengthen resilience against future coronavirus outbreaks and other emerging infectious threats.
Influenza Research and Prevention
This session highlights the latest advances in influenza research, including viral evolution, epidemiology, diagnostics, vaccines, antiviral therapies, and surveillance. It focuses on innovative prevention strategies, outbreak preparedness, and global efforts to reduce the burden of seasonal and pandemic influenza.
Emerging Respiratory Viruses
This session focuses on newly emerging and re-emerging respiratory viruses that pose significant public health challenges. It covers viral transmission, pathogenesis, clinical management, diagnostics, surveillance, vaccine development, antiviral therapies, and strategies for outbreak prevention and pandemic preparedness.
Viral Evolution, Genomics and Molecular Epidemiology
This session explores viral genetic diversity, evolution, and transmission dynamics using genomic and molecular epidemiological approaches. It highlights advances in genome sequencing, mutation analysis, phylogenetics, variant surveillance, and the application of genomic data to outbreak investigation, disease monitoring, and public health decision-making.
Clinical Virology and Viral Pathogenesis
This session focuses on the clinical aspects of viral infections and the mechanisms by which viruses cause disease. It covers viral replication, host–pathogen interactions, disease progression, clinical manifestations, diagnostic approaches, and advances in the development of antiviral therapies and targeted interventions.
Novel and Re-Emerging Infectious Diseases
This session explores newly emerging and re-emerging infectious diseases, their epidemiology, transmission patterns, risk factors, and public health impact. It covers advances in surveillance, early detection, prevention, treatment strategies, and global preparedness to address evolving infectious disease threats.
Emerging Viral Diseases and Global Health
This session focuses on the emergence, transmission, surveillance, prevention, and control of viral diseases with global public health significance. It highlights recent outbreaks, preparedness strategies, advances in diagnostics, vaccines, therapeutics, and international collaborations to strengthen global health security and pandemic resilience.
Submit your abstract
Mail your abstract to contact@srcmeetings.com or submit it online using the form below.
Registration details
Registration windows, pricing categories, and key dates for this conference.
Select the active registration option to continue with attendee details here.
Featured speakers
Speaker profiles will be published soon.
Organizing committee members
contact@srcmeetings.com
Crowne Plaza Orlando Lake Buena Vista
Nearby attractions will be added soon.
ViroSphere 2027: Emerging Viral Threats, Infectious Diseases Antimicrobial Resistance & Public Health Emergencies
contact@srcmeetings.com
For registration, abstract submission, speaker participation, or venue coordination, email our support team or submit your query through the online contact form.